4Bryan BB, Schnitt S J, Collins LC. Ductal carcinoma in situ with basal - like phenotype : a possible precursor to invasive basal - like breast cancer[ J]. Mod Pathol,2006,19(5) :617 -621.
5Reis - Filho JS, Tutt AN. Triple negative tumors: a critical review [ J ]. Histopathology,2008, 52 ( 1 ) : 108 - 118.
6Nielsen TO, Hsu FD, Jensen K,et al. Immunohistochemical and clinical charaterization of the basal - like subtype of invasive breast carcinoma[ J]. Clin Cancer Res,2004,10(16) :5367 - 5374.
7Sasa M, Bando Y, Takahashi M ,et al. Screening for basal marker expression is necessary for decision of therapeutic strategy for triple negative breast cancer[ J]. J Surg Oncol, 2008,97 (1) :30 -34.
8Siziopikou KP, Cobleigh M. The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR2 targeted therapies [ J ]. Breast,2007,16 ( 1 ) : 111 - 112.
9Teng YH, Tan WJ, Thike AA, et al. Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy [ J]. Breast Cancer Res, 2011,13(2) :R35.
10Bergamaschi A, Kim YH, Wang P, et al. Distinct patterns of DNA copy number alteration are associated with different clinic pathological features and gene - expression subtypes of breast cancer [ J ]. Genes Chromosomes Cancer. 2006,45 ( 11 ) : 1033 - 1040.
